.png){kind=icon}
.png){kind=icon}
Return
“Effect of Non-Nucleoside Resistance Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights from the Real-World RELATIVITY Cohort”
.png){kind=icon}
OA
AI
D
J
C
J
M
M
M
L
A
A
S
M
L
D
E
R
N
A
M
C
R
D
L
V
C
M
A
J
H
J
M
P
M
M
O
R
A
L
R
DOI：10.1093/ofid/ofag426.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The impact of pre-existing non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations (RAMs) on the effectiveness of long-acting (LA) cabotegravir (CAB) and rilpivirine (RPV) remains poorly defined, particularly for mutations like K103N that do not directly compromise RPV susceptibility (non-RPV NNRTI RAMs).
Journal
IF:
3.8
Papers:
6.3K
Citations:
1.4W
Organization
Cited Papers